Marquette University

e-Publications@Marquette
Biological Sciences Faculty Research and
Publications

Biological Sciences, Department of

6-2019

Human Genotyping and An Experimental Model Reveal NPR-C as
A Possible Contributor to Morbidity In Coarctation Of The Aorta
John F. LaDisa Jr.
Marquette University, john.ladisa@marquette.edu

Aoy Tomita-Mitchell
Medical College of Wisconsin

Karl D. Stamm
Medical College of Wisconsin

Kathleen Bazan
Medical College of Wisconsin

Donna K. Mahnke
Medical College of Wisconsin

See next page for additional authors

Follow this and additional works at: https://epublications.marquette.edu/bio_fac
Part of the Biology Commons

Recommended Citation
LaDisa, John F. Jr.; Tomita-Mitchell, Aoy; Stamm, Karl D.; Bazan, Kathleen; Mahnke, Donna K.; Goetsch,
Mary A.; Wegter, Brandon; Gerringer, Jesse W.; Repp, Kathryn; Palygin, Oleg; Zietara, Adrian P.; Krolikowski,
Mary M.; Eddinger, Thomas J.; Alli, Abdel A.; and Mitchell, Michael E., "Human Genotyping and An
Experimental Model Reveal NPR-C as A Possible Contributor to Morbidity In Coarctation Of The Aorta"
(2019). Biological Sciences Faculty Research and Publications. 774.
https://epublications.marquette.edu/bio_fac/774

Authors
John F. LaDisa Jr., Aoy Tomita-Mitchell, Karl D. Stamm, Kathleen Bazan, Donna K. Mahnke, Mary A.
Goetsch, Brandon Wegter, Jesse W. Gerringer, Kathryn Repp, Oleg Palygin, Adrian P. Zietara, Mary M.
Krolikowski, Thomas J. Eddinger, Abdel A. Alli, and Michael E. Mitchell

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/bio_fac/774

Marquette University

e-Publications@Marquette
Biology Faculty Research and Publications/College of Arts and Sciences
This paper is NOT THE PUBLISHED VERSION; but the author’s final, peer-reviewed manuscript. The
published version may be accessed by following the link in the citation below.

Physiological Genomics, Vol. 51, No. 6 (June 2019) : 177-185. DOI. This article is © American
Physiological Society and permission has been granted for this version to appear in ePublications@Marquette. American Physiological Society does not grant permission for this article to
be further copied/distributed or hosted elsewhere without the express permission from American
Physiological Society.

Human Genotyping and An Experimental
Model Reveal NPR-C as A Possible Contributor
to Morbidity In Coarctation Of The Aorta
John F. LaDisa Jr.
Department of Biomedical Engineering, Marquette University and the Medical College of Wisconsin, Milwaukee,
Wisconsin
Department of Medicine, Division of Cardiovascular Medicine; Medical College of Wisconsin, Milwaukee,
Wisconsin
Department of Physiology; Medical College of Wisconsin, Milwaukee, Wisconsin

Aoy Tomita-Mitchell
Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

Karl Stamm
Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

Kathleen Bazan
Department of Physiology; Medical College of Wisconsin, Milwaukee, Wisconsin

Donna K. Mahnke
Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

Mary A. Goetsch

Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin

Brandon J. Wegter
Department of Biomedical Engineering, Marquette University and the Medical College of Wisconsin, Milwaukee,
Wisconsin

Jesse W. Gerringer
Department of Biomedical Engineering, Marquette University and the Medical College of Wisconsin, Milwaukee,
Wisconsin

Kathryn Repp
Department of Biomedical Engineering, Marquette University and the Medical College of Wisconsin, Milwaukee,
Wisconsin

Oleg Palygin
Department of Physiology; Medical College of Wisconsin, Milwaukee, Wisconsin

Adrian P. Zietara
Department of Physiology; Medical College of Wisconsin, Milwaukee, Wisconsin

Mary M. Krolikowski
Department of Pediatrics; Medical College of Wisconsin, Milwaukee, Wisconsin

Thomas J. Eddinger
Department of Biological Sciences; Marquette University, Milwaukee, Wisconsin

Abdel A. Alli
Department of Physiology and Functional Genomics and Division of Nephrology, Hypertension, and Renal
Transplantation, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida

Michael E. Mitchell
Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin
Children’s Hospital of Wisconsin, Milwaukee, Wisconsin

Abstract
Coarctation of the aorta (CoA) is a common congenital cardiovascular (CV) defect characterized by a stenosis of
the descending thoracic aorta. Treatment exists, but many patients develop hypertension (HTN). Identifying the
cause of HTN is challenging because of patient variability (e.g., age, follow-up duration, severity) and concurrent
CV abnormalities. Our objective was to conduct RNA sequencing of aortic tissue from humans with CoA to
identify a candidate gene for mechanistic studies of arterial dysfunction in a rabbit model of CoA devoid of the
variability seen with humans. We present the first known evidence of natriuretic peptide receptor C (NPR-C;
aka NPR3) downregulation in human aortic sections subjected to high blood pressure (BP) from CoA versus
normal BP regions (validated to PCR). These changes in NPR-C, a gene associated with BP and proliferation, were
replicated in the rabbit model of CoA. Artery segments from this model were used with human aortic
endothelial cells to reveal the functional relevance of altered NPR-C activity. Results showed decreased
intracellular calcium ([Ca2+]i) activity to C-type natriuretic peptide (CNP). Normal relaxation induced by CNP and
atrial natriuretic peptide was impaired for aortic segments exposed to elevated BP from CoA. Inhibition of NPR-C
(M372049) also impaired aortic relaxation and [Ca2+]i activity. Genotyping of NPR-Cvariants predicted to be
damaging revealed that rs146301345 was enriched in our CoA patients, but sample size limited association with
HTN. These results may ultimately be used to tailor treatment for CoA based on mechanical stimuli, genotyping,
and/or changes in arterial function.

INTRODUCTION
Excessive mechanical forces such as blood pressure (BP), wall tension, and strain contribute to pathologic
remodeling of the aorta and arterial system (22, 39), which can lead to substantial morbidity (24). Morbidity in
the form of hypertension (HTN) is common in children with coarctation of the aorta (CoA), one of the most
common congenital cardiovascular (CV) defects that is characterized by a constriction of the descending thoracic
aorta. Currently there is treatment, but no cure for CoA. The cause of HTN in CoA patients remains unknown
despite the first surgical treatment being conducted ~75 yr ago (18). Genetic factors are believed to be
associated with CoA and may contribute to persistent morbidity after treatment (14, 33). However, the specific
genes contributing to the pathology of CoA, and their functional relevance, remain unknown.
Identifying the mechanisms of morbidity is difficult in humans with CoA due to confounding variables such as
differences in age at repair, time between correction and follow-up, severity of CoA before correction, and
concurrent anomalies (e.g., bicuspid aortic valves or septal defects). While there is likely a causal genetic basis
for the initial presentation of CoA in humans, there are also likely changes in gene expression resulting from
mechanical stimuli on the vasculature as a result of the CoA shortly after birth (9, 16). To address this
complexity, we previously developed a rabbit model that allows us to study the mechanical consequences of
CoA independently of the confounding variables mentioned above (26). This model replicates aortic changes in
humans and mimics correction at various durations using dissolvable suture (Fig. 1). Our results to date using a
putative clinical treatment guideline (20 mmHg BP gradient) with this model have revealed increased medial
wall thickness and stiffening, a phenotypic shift in smooth muscle cells (SMC) to the dedifferentiated state, and
endothelial dysfunction as evident by decreased nitric oxide (NO) relaxation (via acetylcholine stimulation), all of
which persist after correction (25). Microarray analysis of aortic tissue from this model identified several
differentially expressed genes (DEG) in the region exposed to pronounced mechanical stimuli developing from
CoA (19). The objective of the current investigation was to use RNA sequencing (RNA-Seq) of aortic tissue from
humans with CoA to identify one or more candidate genes for use in future mechanistic studies of coarctation
induced arterial dysfunction. We then sought to determine the association of any candidate genes with the
likelihood of HTN in a larger cohort of patients with CoA from our center. Specifically, we present the first known
evidence of natriuretic peptide receptor C (NPR-C; also known as NPR3) downregulation in humans treated for
CoA and use our rabbit model of CoA to show the functional relevance of coarctation induced changes in NPR-C.

Fig. 1.Magnetic resonance images showing the similarity between untreated and treated coarctation of the
aorta (CoA) in humans (left top) vs. a rabbit model (left bottom) developed to study mechanisms of arterial
dysfunction in the absence of concurrent anomalies. Yellow arrows denote treatment sites. The right images
show CoA suture (black arrows) and resulting blood pressure gradient (BPG) for groups of juvenile rabbits (n =

7/group) with 20 mmHg BPG. Symbols indicate significantly (P < 0.05) different from Control (*) and Treated (§)
groups.

METHODS
All procedures were reviewed and approved by the Institutional Review Board and Institutional Animal Care and
Use Committee of the Children’s Hospital of Wisconsin, Medical College of Wisconsin, and Marquette University
as previously described (26, 34).

Human RNA sequencing and genotyping.
Samples for the current study were extracted from the Congenital Heart Disease Tissue Bank at our institution
for two purposes. Sections from above (proximal; high BP region) and below (distal; low BP region) the
coarctation were extracted from patients for RNA-Seq and transcriptome analysis. White blood cell DNA from
242 CoA patients was subsequently used for genotyping as described in more detail below. All tissue was
obtained after consent and at the time of corrective surgery.

Transcriptome isolation.
RNA-Seq analysis of samples was performed similar to details described previously (35). Briefly, aortic tissue for
RNA-Seq was selected from six CoA patients (average age = 6.5 yr, range 0.31–11 yr; Table 1) with an upper
extremity systolic BP >99th percentile for their sex, height, and age according to the National High Blood
Pressure Education Program (NHBPEP) Working Group on Children and Adolescents (27a), thereby focusing on
mechanical consequences imposed by the coarctation. RNA was isolated from aortic samples (~10 mg) by
enzymatic digestion with an Ambion MELT kit (Invitrogen), which includes an “on-bead” DNase digestion step to
remove contaminating genomic DNA. Samples were homogenized with glass tissue grinders needed for fibrous
samples. The Qiagen RNeasy Fibrous Minikit (Qiagen; Valencia, CA) was then used according to the
manufacturer’s instructions. Isolated RNA was of high quality as determined by Bioanalyzer 2100 RNA integrity
number (Table 1; Agilent Technologies). RNA sequencing libraries were prepared from 500 ng total RNA using
the Illumina TruSeq kit (version 2.5). Samples were spiked with external RNA controls (ERCC sequences; Ambion
Life Technologies, Grand Island, NY). Unique indexes were introduced according to the protocol in order for
sample multiplexing during the sequencing run. Library quantitation was accomplished by quantitative (q)PCR,
and subsequent sequencing was carried out on an Illumina HiSeq 2000 platform. Approximately 35 million
paired-end reads were generated per sample.
Table 1. Patient characteristics, sample locations, and RNA quality
Subject

Age, yr

Sex

1

5.6

M

Preop BP,
systolic/diastolic
139/91

2

9.3

M

126/71

3

0.3

M

118/69

4

8.0

F

133/58

F
M

134/80
130/89

5
11
6
5.2
Average (SD)
6.5 (3.7)
BP, blood pressure.

Sample
Location
proximal
distal
proximal
distal
proximal
distal
proximal
distal
proximal
distal
Average (SD)

RNA Integrity
#
8.3
8.2
7.6
8.7
7.0
8.2
8.0
8.1
7.4
7.8
7.9 (0.49)

Matched Pair (yes
= X)
X
X
X
X

Transcriptome data analysis.
Illumina HiSeq 2000 paired-end reads were mapped to the human genome (NCBI b37) using gapped alignment
software Bowtie (36) under RSEM 1.2.7. Quantification to posterior mean estimate transcripts per million (TPM)
was performed by RSEM (http://deweylab.biostat.wisc.edu/rsem/) across a transcriptome reference of 38,642
from RefSeq (genes, alternative transcripts, mitochondrial sequences, and spiked-in ERCC controls). Transcripts
were analyzed with EdgeR by scaling TPM to produce pseudocounts, calculating normalization factors, then
estimating GLM common, trended, and tagwise dispersions. EdgeR is a standard package of the R programming
language for differential expression analysis. A likelihood ratio test evaluated each transcript’s model
significance by tissue location (proximal vs. distal). The generalized linear modeling functionality in EdgeR was
used to perform paired samples test (31). A P value < 0.05 was considered statistically significant, yielding DEG.
Results were filtered to retain those transcripts with absolute log fold change and expression (logCPM) greater
than one. EdgeR results were processed by removing DEG within the proximal vs. distal sections for any
individual subject, thereby leaving only those DEG with significant changes in expression across all patients.
DEG from the RNA-Seq analysis of aortic tissue from humans with CoA above were compared with those from a
prior study generating DEG from proximal aortic tissue of untreated CoA, treated CoA, or control rabbits (19).
Three common DEG emerged: DENN domain containing 2D (DENND2D), ArfGAP with coiled-coil, ankyrin repeat
and PH domains 1 (ACAP1), and NPR-C. In contrast to DENND2D and ACAP1, a comprehensive literature search
suggested a potential role for NPR-C in the vasculature (3, 5, 15, 21). NPR-C was therefore determined to be the
most promising and pragmatic candidate for more detailed functional analysis in the rabbit model of CoA and
cell culture approaches. The relative quantification of NPR-C vs. GAPDH was then compared between RNA-Seq
results and qPCR (TaqMan Assay ID: Hs01099013_m1).

Genotyping for NPR-C variants.
At the time of study, there were five known single-nucleotide polymorphisms (SNPs) for NPR-C that are
associated with high systolic BP or HTN (Table 2). We identified one additional NPR-C variant (Table
2; rs146301345) from a population of ~200 patients whose tissue underwent whole exome or whole genome
sequencing at our center previously (13, 35). These patients had hypoplastic left heart syndrome (HLHS), which
is a congenital cardiovascular disease often including CoA (67–80%) (12).

Table 2. SNPs associated with elevated BP and/or HTN
Reference
SNP
rs1173756
rs1173766
rs1173771
rs1421811
rs2270915

MAF (1000 Genomes
Project)
t = 0.3740/1873
t = 0.3988/1997
A = 0.3391/1698
G = 0.2778/1391
G = 0.1955/979

Cscore
0.13
0.06
-0.14
0.06
1.90

Associated Phenotype

Supporting
Literature
Wain et al.
Kato et al.
Ehret et al.
Johnson et al.
Saulnier et al.

systolic BP
HTN; 1.16 odds ratio
systolic BP
systolic BP
systolic BP; 4 yr CV mortality
12.5%
rs146301345
A = 0.0008/4
2.55
height
Marouli et al.
CV, cardiovascular; HTN, hypertension; MAF, minor allele frequency; SNP, single nucleotide polymorphism.

PMID

TaqMan Assay ID

21909110
21572416
21909110,21909115
22100073
21464461

C 8809430_1_
C 27051776_10
C 8809478_10
C 8809215_10
C 15958985_20

28146470

C_171467879_10

Several scoring algorithms (2, 28, 30) were employed to assess functional damage of variants and calculate a Cscore (17). Analysis of rs2270915 within the group of HLHS patients from our center mentioned above (some of
which also have CoA) revealed a frequency of ~65%, as compared with 14–22% in U.S. populations without CoA.
Interestingly, rs146301345 was present in two of these patients studied. These two SNPs are likely to
render NPR-C nonfunctional, with scoring values indicating they are highly intolerant and damaging
(e.g.; rs2270915 C-score = 1.90 and rs146301345 C-score = 2.55). Detection of these two NPR-C variants was
therefore performed using TaqMan Predesigned SNP Genotyping Assays and buffy coat DNA from 242 total CoA
patient samples obtained at the time of corrective surgery. Primers and probes were purchased from Applied
Biosystems (Foster City, CA), and probes were labeled with the fluorescent dyes VIC and FAM. Assays were
performed using TaqMan Universal Master Mix, with 20 ng of DNA per reaction. The reaction was carried out
with a total reaction volume of 5 μl, following an amplification protocol suggested by the manufacturer, with 30
DNA samples run per plate. Genotype was called using the QuantStudio 7 Flex Real-Time PCR System in the
presence of a known positive control for each genotype and a no template negative control. Allele and genotype
frequencies of NPR-C were obtained by direct counting. Comparison of variant frequencies in our CoA patients
to the global population was done using the minor allele frequency (MAF) calculation. The global population
information was found on NCBI’s SNP database (dbSNP) 1000 Genomes project.

Relating NPR-C variants to HTN in CoA patients.
Clinical records were retrospectively analyzed to relate NPR-C variants to HTN status using age, sex, height, and
follow-up BP. Patients <18 yr at follow-up were evaluated using the NHBPEP Working Group on Children and
Adolescents (27a) criteria for systolic and diastolic BP: normal (≤50th percentile BP), pre-HTN (≥50th but <99th
percentile BP), HTN (≥99th percentile BP). Patients ≥18 yr at follow-up were evaluated using Joint National
Committee seven guidelines for BP: normal (<120/80 mmHg), pre-HTN (120–139/80–89 mmHg), HTN
(includes stage 1: 140–159/90–99 mmHg and stage 2: >160/>100 mmHg). An error-correcting output code for
multiclass learning (i.e., machine learning) in MATLAB was proposed with a range of classifiers (e.g., Logistic
Regression, Support Vector Machines, Ensemble, etc.) and predictors (e.g., the patient covariates such as age
and sex) to determine if either variant alone, in concert with each other and other covariates, is sufficiently
predictive of HTN status to be applied with future CoA patients.

Assessing functional significance using cell culture and intact arteries.
Cell culture and ex vivo intact artery approaches were used to assess the potential functional relevance of
changes in NPR-C using associated agonists and inhibitors. Human aortic endothelial cells (HAEC) from Cell
Biologics (Chicago, IL) were cultured with the manufacturer’s recommended media. HAEC were split in a 1:3
ratio every 3–4 days after initial plating from a frozen vial into a T25 cell culture flask. The cells were transferred
to six-well plates at passage 8 and left to grow for 4–5 days to reach confluence. HAEC (n = 4/group) intracellular
calcium transients ([Ca2+]i) were recorded during experimentation with a confocal imaging system Leica TCS
MP5. Imaging settings were chosen to allow for continuous image capture every 2.3 s and set for a maximum
duration of 5 min. After starting acquisition, C-type natriuretic peptide [CNP; induces relaxation via NPR-C (4, 7)]
or cANF4–23 (specific NPR-C agonist) was diluted into the dish to concentrations of 1.5e-6M and 7.5e-7M,
respectively. These doses balanced response to an agent with cellular toxicity. The experiment ended, and the
image stack was saved when no additional changes in intensity were observed for 20 s.
Images were quantified using the Loci Tools plugin within ImageJ (National Institute of Health). Briefly, image
frames corresponding to times just before drug administration, and the peak response time (for dimming or
elimination) were determined. The Measurement option within the Analyze tool was then employed using at
least four cells at each time point. Resulting intensities were normalized to background. The EC response to CNP
and cANF4–23 was also quantified after pretreatment with the NPR-C specific inhibitor, M372049, (AstraZeneca)

(37) for 45 min. Experiments were repeated using four separate plates for each group. Normalized intensities
were then averaged, and statistical analysis was performed as described in the myography methods below.
To confirm the HAEC experiments above replicate the in vivo condition, we assessed the endothelial response to
CNP under normal deformation and pathologic conditions from CoA with intact aortic sections from the
transverse arch of rabbits (n = 5) exposed to CoA induced by wire of known diameter (0.051–0.064”). Data from
control rabbits (n = 3) were also obtained. Specifically, two-photon microscopy was used to visualize and
quantify [Ca2+]i mobilization in response to CNP for endothelial cells from proximal and distal aortic sections of
Control and CoA rabbits exposed to CoA by methods described in detail elsewhere (10, 11, 29). Briefly, aortic
segments were extracted, opened longitudinally, and loaded with the Ca2+ dye, Fluo-4AM (5 μM, Life
Technologies), using 0.05% pluronic acid (Pluronic F-127, Sigma-Aldrich) in physiological salt solution (PSS) for 1
h. Aortas were washed and then transferred to a silicone-coated plate containing 2 mM Ca2+ buffer, where they
were pinned down with the endothelium facing upright. The plate was then transferred to an upright Olympus
Fluoview FV1000 microscope (Olympus) equipped with Ti:sapphire lasers tuned to 820 nm and imaged with a
25X (N.A. 1.05 and working distance 2 mm) water-immersion objective lens (XLPL25XWMP, Olympus). The
fluorescent response was imaged within EC after addition of 10 µM CNP. Images were taken every 1.6 s. Average
Ca2+ transients of EC were calculated for proximal and distal sections (n ≥ 9 cells per location). One rabbit of each
group was used to optimize incubation and signal intensity protocols for use with two-photon imaging. Two
samples from each vascular region (i.e., proximal and distal) were studied for each rabbit.
The arterial response to potential changes in NPR-C was measured by myography (26). Relaxation was measured
for endothelium-intact arterial rings from proximal and distal locations (n = 2/location) of the same CoA and
Control rabbits used for two-photon microscopy. Relaxation via NPR-C was studied in cumulative doses (10−9 to
10−6 M) of CNP and atrial natriuretic peptide (ANP), which is also reported to have a strong affinity for NPR-C
(23). Aortic segments from the descending thoracic aorta upstream of the coarctation (i.e., proximal) and just
downstream of any poststenotic dilatation (i.e., distal) were precontracted with 0.32 μM phenylephrine (PE)
before each dose response, and relaxation curves were constructed as percentages of precontracted tension.
Care was taken to ensure and present data only from samples with a similar level of tension at the start of each
cumulative dose response. Samples were rinsed with fresh PSS three times and allowed to relax back to resting
tension after the conclusion of each dose response. In separate trials, arteries were incubated with 10 μM of the
NPR-C specific inhibitor (37) M372049 for 30 min. Additional CNP and ANP cumulative dose responses were then
conducted in the presence of the inhibitor. Statistical analysis was conducted by one-way multiple analysis of
variance (ANOVA). A P value <0.05 was considered statistically significant.

RESULTS
Transcriptome analysis.
RNA-Seq of aortic tissue harvested during surgical treatment of human CoA patients revealed a statistically
significant reduction in the normalized expression of NPR-C for proximal as compared with distal sections (Fig.
2A). Relative quantification of NPR-C vs. GAPDH from these samples showed a good correlation (R-value of 0.8)
with those from qPCR. Rabbit aortic tissue from the proximal region exposed to elevated BP due to the presence
of a 20 mmHg coarctation (19) caused a decrease in NPR-C intensity in untreated as compared with control
rabbits, and this decrease persisted in proximal aortic tissue of rabbits whose coarctation had been relieved by
resorption of the dissolvable Vicryl suture used to create the initial constriction.

Fig. 2.Normalized natriuretic peptide receptor C (NPR-C) expression from RNA sequencing (RNA-Seq) of aortic
tissue harvested during surgical treatment of human CoA patients (A). All patients had systolic blood pressure
(BP) >99% for age, thus underscoring the mechanical impact of CoA. Prior microarray results from a rabbit model
of CoA (B) also showed a decrease in NPR-C transcript levels in proximal aorta exposed to elevated BP from the
presence of a coarctation. Data expressed as means ± SE. *P < 0.05.

Cell culture and intact artery experiments.
HAEC showed rapid decrease in cytosolic [Ca2+]i response (Fluo-4 AM) in response to 1.5e-6M CNP relative to the
baseline period before CNP administration. The NPR-C agonist cANF4–23 increased [Ca2+]i level at a dose of 7.5e7M. Both responses were blocked by the NPR-C inhibitor M372049 (Fig. 3) when evaluated at the same
respective time durations following respective substance administration.

Fig. 3.Human aortic endothelial cells (HAEC) showed decreased intracellular calcium ([Ca2+]i) response to C-type
natriuretic peptide (CNP, 1.5e-6M). The NPR-C agonist cANF4–23 (7.5e-7M) increased [Ca2+]i release. Both
responses were blocked by the NPR-C inhibitor M372049. *P < 0.05 vs. Baseline.
The average catheter-based BP gradient measured in CoA rabbits of the current study was 17 mmHg, while that
measured from spatially equivalent locations of Control rabbits was 1 mmHg. Similar to HAEC, two-photon
imaging of EC within intact aortic segments from proximal and distal locations of Control rabbits revealed a
decrease in [Ca2+]i in response to CNP (Fig. 4). This decrease in was also observed for intact aortic segments from
the distal aorta of CoA rabbits where there was normal BP in vivo. In contrast, for CoA rabbits the
[Ca2+]i response to CNP from proximal aorta segments experiencing high BP in vivo was significantly attenuated
when compared with the distal segments (Fig. 4).

Fig. 4.Two-photon images of [Ca2+]i levels from endothelial cells (EC) within intact sections for groups of Control
and CoA rabbits at baseline and upon administering CNP (10 μM). Temporal results show differences in proximal
vs. distal locations (n = 9 EC/location). CNP decreased [Ca2+]i response for ECs within both sections of Control
rabbits and distal sections of CoA rabbits, but this response is absent in proximal sections of CoA rabbit, which
were exposed to high BP in vivo.
Figure 5 shows active relaxation of the aorta to CNP and ANP from CoA and Control rabbits. There were no
differences in relaxation of proximal vs. distal aortic rings from Control rabbits when exposed to increasing doses
of CNP or ANP (Fig. 5, top row). In contrast, there was a statistically significant attenuation of relaxation in
proximal as compared with distal aortic rings for CoA rabbits when exposed to all doses of CNP and ANP (Fig.
5, middle row). ANP-induced relaxation of aortic rings from proximal and distal locations was nearly twice that
observed with CNP. Dose-dependent relaxation to CNP and ANP was impaired and not statistically different
between proximal and distal aortic rings following pretreatment with the NPR-C inhibitor M372049 (Fig.
5, bottom row).

Fig. 5.Dose-dependent relaxation of the proximal and distal aorta to CNP (left) and atrial natriuretic peptide
(ANP, right) for groups of Control and CoA rabbits. Relaxation of proximal and distal aortic rings was not
different in samples from Control rabbits (top row). There was statistically significant attenuation of relaxation in
proximal as compared with distal aortic rings for CoA rabbits when exposed to all doses of CNP and ANP
(middle row). Residual relaxation to these peptides was abolished by pretreatment with the NPR-C inhibitor
M372049 (bottom row). PE, phenylephrine.

Genotyping of NPR-C variants.
DNA samples of patients from our center were genotyped to determine if HTN in CoA patients may be
associated with the NPR-C variants rs2270915 and rs146301345, which are predicted to be highly intolerant and
damaging. Figure 6 shows allelic discrimination plots from samples on representative plates for each variant.
Figure 6, left, reveals the majority of CoA patients have an rs2270915 genotype of AA, while AG is also common.
We therefore focused on samples from CoA patients that were homozygous for the opposite allele (GG; within
the ellipse). Figure 6, right, shows samples for rs146301345 that are homozygous for the VIC probe, which
corresponds to a genotype of GG. This is the common genotype in the human population, therefore focusing our
interest to samples that were heterozygous, as shown by those within the ellipse. The frequencies of NPRC variant genotypes in our CoA cohort from all plates are summarized in Table 3.

Fig. 6.Allelic discrimination plots for a representative plate from each NPR-C variant. Samples with the
noncommon genotype for each variant are indicated by the ellipses.
Table 3. Frequency of NPR-C variant genotypes in the current cohort of CoA patients
Genotype
A/A
G/A
G/A
46301345 A/A
A/G
G/G
rs2270915

Patients, n
155
71
16
0
5
237

Percentage
64.1
29.3
6.61
0
2.07
97.9

For rs2270915, the minor allele is G, which has a frequency of 19.6% in the global population, having been
observed 979 times in the sample population of 2,500 people (or 5,000 chromosomes). Similarly, our current
cohort of CoA patients revealed a frequency for rs2270915 of 21.3%. The minor allele for rs2270915 was
detected 103 times in 242 patient samples (484 chromosomes). The minor allele for rs146301345 is A. This
variant is more rare in the global population with a frequency of only 0.08% (4 of 2,500 people, or 5,000
chromosomes). In contrast, rs146301345 was significantly enriched in our cohort of CoA patients having been
observed five times in just 242 people (or 484 chromosomes).
Unfortunately, rs2270915 and rs146301345 alone, or together, did not have sufficient predictability to
determine HTN status in our cohort. Calculation of sample size using the descriptive statistics above for these
variants in our CoA cohort indicates ~2,500 patients must be studied to determine the ability of rs146301345 to
predict hypertensive status.

DISCUSSION
For unknown reasons, treated CoA patients often have a reduced life expectancy from CV morbidity, primarily
from HTN (8). Upon closer review, there are several potential contributors to arterial pathology in CoA.
Putatively, there is a causal genetic basis for the initial narrowing. The prevailing causal hypothesis is based on
histology showing that tissue with features similar to the ductus arteriosus (DA) also exists near the coarctation,
suggesting CoA may be created during closure of the DA in the first week of life (9, 16). Closure of the DA leads

to the secondary consequence of exposing the aortic arch and arteries above the coarctation to mechanical
stimuli including elevated BP and a gradient across the narrowing. Treatment approaches that mitigate the
secondary consequence of CoA may ultimately reduce morbidity for a large number of CoA patients and
individuals with refractory HTN attributable to prolonged mechanical stimuli.
The critical barriers to identifying the mechanisms of morbidity in humans with CoA from causal or mechanical
sources include a relatively small number of heterogeneous patients at each center. To circumvent these
barriers the current investigation analyzed gene expression data from an animal model of CoA largely devoid of
the heterogeneity seen clinically (26) based on RNA-Seq results of human aortic tissue harvested during surgical
treatment. The goal of this approach was to identify a candidate gene that could be further studied in the rabbit,
but that was motivated from humans with CoA who had upper extremity systolic BP >99th percentile for their
sex, height, and age, thereby focusing on mechanical consequences. The primary finding of the current
investigation is that RNA-Seq from humans treated for CoA revealed downregulation of NPR-C in proximal
sections of the thoracic aorta subjected to high BP when compared with sections from regions in the distal
thoracic aorta exposed to normal BP. Importantly, microarray data from our experimental rabbit model of CoA
also showed downregulation of NPR-C in proximal aortas from both CoA and treated rabbits experiencing high
BP, as compared with controls experiencing normal BP (Fig. 2).
NPR-C is a single transmembrane receptor coupled to the activation of phospholipase C beta-3 (27) through
beta-gamma subunits and adenylyl cyclase inhibition via inhibitory guanine nucleotide regulatory protein (Gi)
(3). NPR-C is found in many tissues including SMC where it has been shown to play a role inhibiting proliferation
(5, 15), and endothelial cells where recent literature suggests a role in re-endothelialization and viability under
healthy conditions (15). Prior studies also point to a role in regulating BP (3) as systemic administration of an
NPR-C agonist attenuated high BP in spontaneously hypertensive rats by inhibiting enhanced levels of Gi (21).
NPR-C is one of three receptors for natriuretic peptides that include ANP, brain (BNP) and CNP. ANP and BNP are
mostly found in the atria and ventricles, whereas CNP is abundantly expressed in vascular EC (4, 7). Activation of
NPR-C increases eNOS activity resulting in the formation of NO and vasorelaxation via cGMP. While this prior
literature implicates NPR-C in arterial dysfunction, the current investigation is the first to show altered NPRC transcript levels in aortic tissue from human CoA patients.
Similarity in trends between the current human RNA-Seq results and prior microarray results from rabbits with
CoA suggest that the rabbit provides a unique model to further unravel the contribution of NPR-C to CoAinduced arterial dysfunction. Indeed, the data in Figs. 4 and 5 show the functional relevance of NPR-C
impairment in the vasculature using this model and are consistent with the cell culture results in Fig. 3.
Collectively these data provide the first exciting evidence of a functional relevance for changes in NPR-C from
CoA.
The current results show promising evidence of functional ramifications to altered NPR-C activity from
pronounced mechanical stimuli. Interestingly, genome-wide association studies (GWAS) have uncovered several
known SNPs for NPR-C that are associated with high systolic BP or HTN (Table 2). For
example, rs2270915 presents in 14–22% of U.S. populations (1000 Genomes Project), with the altered genotype
having higher systolic BP and sodium response (32). While our rabbit model of surgical coarctation induction
certainly suggests decreased NPR-C transcript levels are a secondary consequence of mechanical stimuli, aortic
tissue from humans with CoA that was used for RNA-Seq may theoretically include changes in gene expression
from causal as well as mechanical sources. We attempted to mitigate this issue by using tissue from patients
who had upper extremity systolic BP >99th percentile for their sex, height, and age, thereby focusing on the
mechanical consequences of the coarctation. Nevertheless, an alternative hypothesis is that normotensive CoA
patients may simply have a normal NPR-C genotype. The ability to genotype CoA patients for NPR-C variants is
attractive as a potential screening tool, as it could explain the presence of HTN even in CoA patients who have

undergone optimal treatment with no residual blood pressure gradient. While the MAF for rs2270915 in the
current CoA cohort was not different from the general population, the more rare SNP, rs146301345, was
enriched in our cohort of coarctation patients. This finding suggests that in addition to mediating coarctationinduced arterial dysfunction from mechanical stimuli, NPR-C may in some way be causal for HTN in CoA. The full
understanding of this finding is not currently known and may elude researchers for some time as our sample size
estimates from power analyses indicate ~2,500 CoA patients will be needed to statistically determine
whether rs146301345 is associated with HTN. This represents a large number as most centers will see ~20 new
CoA patients annually. Moreover, updated guidelines for the prevention, detection, evaluation, and
management of BP were recent released, which includes BP categories that differ slightly from those used in the
current study (38). Future studies using the updated guideline and categories will be needed to determine
potential association with HTN. Additional studies will also be needed to better understand the precise
mechanism(s) by which NPR-C variants seen clinically result in HTN via markers of endothelial function (e.g., NO
release).
The current results should be interpreted relative to several potential limitations. Healthy aortic tissue was not
available from an age- and sex-matched cohort of subjects. We therefore used distal aortic tissue we know to be
exposed to a normal range of BP (20, 25), even though other mechanical stimuli such as wall shear stress may
impact gene expression downstream of the coarctation. We acknowledge that different approaches were used
to quantify changes in gene expression between humans and rabbits exposed to CoA. This was unfortunate but
is an unavoidable consequence resulting from the continuing evolution of genomic tools. To mitigate
differences, DEG from completion of the data analysis process applied for each respective approach (RNA-Seq
vs. microarray) were compared with identified candidate genes. Moreover, the data featured here in support of
a functional role for altered NPR-C activity, and that rs146301345 seems to be enriched in our coarctation
patients, suggest that NPR-C is indeed a target of relevance to CoA. In contrast to finding new rare SNPs, we
focused on SNPs known to be associated with high BP given the prevalence of HTN in CoA (32.5%, range 25–
68%) (6). Moreover, uncovering new variants from the population of CoA patients at one center is difficult due
to a limited sample size. Two-photon imaging is best performed on fresh tissue sections, and the extended
duration of associated imaging sessions following tissue harvest precluded the additional study of responses to
ANP via two-photon imaging as was performed via myography.
In conclusion, the current investigation identified NPR-C as a potential contributor to arterial dysfunction in CoA
patients for the first time. Specifically, RNA-Seq of tissue from humans with CoA showed downregulation
of NPR-C in proximal aortic sections exposed to elevated BP, as compared with distal sections from
normotensive regions. Complementary microarray data from an experimental rabbit model of CoA similarly
showed downregulation of NPR-C in proximal aortas from both CoA and treated rabbits experiencing high BP as
compared with control rabbits experiencing normal BP. Intact artery segments from this experimental model
were used with HAEC to obtain data on the functional ramifications of altered NPR-C activity. Both approaches
showed decreased [Ca2+]i activity in response to CNP administration under normal conditions. The normal
response to CNP and ANP is abolished for aortic segments previously exposed to elevated BP from CoA.
Moreover, NPR-C could represent a potential therapeutic target as pharmacological inhibition resulted in
impaired aortic relaxation. Of the known NPR-Cvariants predicted to be highly intolerant and
damaging, rs146301345 was found to be enriched in our cohort of CoA patients, but a small samples size
precluded determination of its potential association with HTN in CoA patients. These results may ultimately be
used to suggest a new paradigm for CoA treatment based on mechanical stimuli, genotyping, and/or changes in
arterial function assessed clinically after confirmation of the current important findings in larger studies.
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